换一批
第一作者：
M,Kalaivani
第一单位：
a Scientific Assistant; Biologics Section; Indian Pharmacopoeia Commission ; Ministry of Health and Family Welfare (Govt. of India) ; Ghaziabad , India.
作者：
关键词
ADR, adverse drug reactionsADR/E, adverse drug reactions/eventAMCs, ADR monitoring centersCDSCO, Central Drugs Standard Control OrganizationCLL, chronic lymphocytic leukemiaDCGI, Drug Controller General of IndiaEMA, European Medicines AgencyEU, European UnionGEAC, Genetic Engineering Appraisal CommitteeHBV, hepatitis B virusICSRs, Individual Case Safety ReportsIPC, Indian Pharmacopoeia CommissionMHRA, Medicines and Healthcare Products Regulatory AgencyMedDRA, Medical Dictionary for Regulatory ActivitiesMoEF, Ministry of Environment and ForestsMoHFW, Ministry of Health and Family WelfareNCC-PvPINCC-PvPI, National Coordination Centre-Pharmacovigilance Program of IndiaNHL, non Hodgkin lymphomaNRA, National Regulatory AuthorityPML, progressive multifocal leukoencephalopathyPSUR, Periodic Safety Updates ReportRCGM, Review Committee on Genetic ManipulationSOC, System Organ ClassUS, Unites States of AmericaUSFDA, United States Food and Drug AdministrationVigiflowWHO, World Health OrganizationmAb, monoclonal antibodymAbs, monoclonal antibodiesmonoclonal antibodyrDNA, recombinant DNAspontaneous reportingtargeted pharmacovigilance
DOI
10.4161/19420862.2014.985547
PMID
25523367
发布时间
2018-11-13
- 浏览96
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
